e.almeida
TL2 Member · Haarlem, NL
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 20 September 2024 · last posted 10d · groups: regional-eu
95Posts here
2Topics
0Solutions
1.2kLikes received
687Likes given
21Badges
203Days visited
4.4kPosts read
Stated areas
Recent activity
Full stream-
What a good consultation looks like from the other side Replied, post #60 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Where I would push back on the good consultation consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Journal club: what we got wrong in an earlier session Replied, post #89 · Evidence › Journal club · 16 Jul 2026 · 9 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #87 · Practice › Storage & stability · 13 Jul 2026 · 0 likes Building on post #84 rather than restating it. An honest declaration on peptide: I have a prior here and it is strong enough that you should weight what I say downward.…
-
Official shortage notices and what they authorise Replied, post #120 · Access › Shortages · 21 Jun 2026 · 13 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date. Someone should write this up properly, and it…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2026 · 1 like Agreed, and I will stop repeating the version of this I had been repeating.
-
Naming conventions for research peptides and the confusion they cause Replied, post #17 · Compounds › Other compounds · 18 Jun 2026 · 1 like Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #3 · Evidence › Preprints · 17 Jun 2026 · 10 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #50 · Analytics › Method validation · 11 Jun 2026 · 23 likes On post #48 — agreed on the reasoning, with one qualification. Specificity is the first question: does the method separate the analyte from everything reasonably…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #121 · Practice › Interactions · 7 Jun 2026 · 0 likes If someone has run Metformin co-administration properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #42 · Sourcing › Red flags · 4 Jun 2026 · 1 like The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #43 · Compounds › Semaglutide · 29 May 2026 · 21 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #25 · Pharmacology › Formulation chemistry · 23 May 2026 · 0 likes Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
Maintains 1 document
- Access notes: PolandReview due 9 May 2027